These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 32671288)

  • 1. Advanced Coats' disease treated with intravitreal brolucizumab combined with laser photocoagulation.
    Patel NA; Berrocal AM; Murray TG; Villegas VM
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100815. PubMed ID: 32671288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Navigated Focal Laser of Macular Telangiectasia Type I (Adult-Onset Coats' Disease).
    Amoroso F; Miere A; Colantuono D; Pedinielli A; Cohen SY; Souied E
    Ophthalmic Surg Lasers Imaging Retina; 2024 Sep; 55(9):545-551. PubMed ID: 38917396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable Fluocinolone Implant for the Management of Cystoid Macular Edema in Coats' Disease.
    Patel KG; Abbey AM
    Ophthalmic Surg Lasers Imaging Retina; 2024 Aug; ():1-3. PubMed ID: 39133686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert Opinion on Management of Intraocular Inflammation, Retinal Vasculitis, and Vascular Occlusion after Brolucizumab Treatment.
    Baumal CR; Bodaghi B; Singer M; Tanzer DJ; Seres A; Joshi MR; Feltgen N; Gale R
    Ophthalmol Retina; 2021 Jun; 5(6):519-527. PubMed ID: 33007521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brolucizumab-early real-world experience: BREW study.
    Sharma A; Kumar N; Parachuri N; Sadda SR; Corradetti G; Heier J; Chin AT; Boyer D; Dayani P; Arepalli S; Kaiser P
    Eye (Lond); 2021 Apr; 35(4):1045-1047. PubMed ID: 32709960
    [No Abstract]   [Full Text] [Related]  

  • 6. Short-term outcomes following treatment of recalcitrant cystoid macular edema secondary to radiation maculopathy using intravitreal brolucizumab.
    Corradetti G; Corvi F; Juhn A; Sadda SR
    Am J Ophthalmol Case Rep; 2020 Dec; 20():100981. PubMed ID: 33145457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brolucizumab-related retinal vasculitis with exacerbation following ranibizumab retreatment: A clinicopathologic case study.
    Iyer PG; Peden MC; Suñer IJ; Patel N; Dubovy SR; Albini TA
    Am J Ophthalmol Case Rep; 2020 Dec; 20():100989. PubMed ID: 33294727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate onset of sterile endophthalmitis with hypopyon after intravitreal Brolucizumab in a case of polypoidal choroidal vasculopathy.
    Narayanan R; Tyagi M; Gupta SR; Nayaka A; Jayadev C
    Indian J Ophthalmol; 2021 Feb; 69(2):469-470. PubMed ID: 33463623
    [No Abstract]   [Full Text] [Related]  

  • 9. Three cases of brolucizumab-associated retinal vasculitis treated with systemic and local steroid therapy.
    Kataoka K; Horiguchi E; Kawano K; Ushida H; Nakano Y; Ito Y; Terasaki H
    Jpn J Ophthalmol; 2021 Mar; 65(2):199-207. PubMed ID: 33543352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brolucizumab: A Newly Developed Anti-VEGF Molecule for the Treatment of Neovascular Age-Related Macular Degeneration.
    Tadayoni R; Sararols L; Weissgerber G; Verma R; Clemens A; Holz FG
    Ophthalmologica; 2021; 244(2):93-101. PubMed ID: 33197916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brolucizumab-related retinal vasculitis: emerging disconnect between clinical trials and real world.
    Sharma A; Kumar N; Parachuri N; Singh S; Bandello F; Kuppermann BD; Loewenstein A
    Eye (Lond); 2021 May; 35(5):1292-1294. PubMed ID: 33082532
    [No Abstract]   [Full Text] [Related]  

  • 12. Retinal Vasculitis After Administration of Brolucizumab Resulting in Severe Loss of Visual Acuity.
    Kondapalli SSA
    JAMA Ophthalmol; 2020 Oct; 138(10):1103-1104. PubMed ID: 32761135
    [No Abstract]   [Full Text] [Related]  

  • 13. Three Japanese cases of intraocular inflammation after intravitreal brolucizumab injections in one clinic.
    Hikichi T
    Jpn J Ophthalmol; 2021 Mar; 65(2):208-214. PubMed ID: 33543351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Brolucizumab-early real-world experience: BREW study.
    Sharma A; Kumar N; Parachuri N; Sadda SR; Corradetti G; Heier J; Chin AT; Boyer D; Dayani P; Arepalli S; Kaiser P
    Eye (Lond); 2021 Apr; 35(4):1286. PubMed ID: 33323990
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
    Monés J; Srivastava SK; Jaffe GJ; Tadayoni R; Albini TA; Kaiser PK; Holz FG; Korobelnik JF; Kim IK; Pruente C; Murray TG; Heier JS
    Ophthalmology; 2021 Jul; 128(7):1050-1059. PubMed ID: 33207259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaso-occlusive retinitis following intravitreal injection of brolucizumab].
    Angerer MPM; Neuburger M; Hille K; Horn PC
    Ophthalmologe; 2021 Oct; 118(10):1048-1050. PubMed ID: 33141333
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intraocular inflammation with brolucizumab use : Patient management-diagnosis-therapy].
    Holz FG; Heinz C; Wolf A; Hoerauf H; Pleyer U
    Ophthalmologe; 2021 Mar; 118(3):248-256. PubMed ID: 33555415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-Year Results of Management of Adult-Onset Coats' Disease by Possibly Targeting Placental Growth Factor.
    Alsaggaf K; Jalloun M; Alkhotani W; Albeedh M
    Cureus; 2020 Sep; 12(9):e10652. PubMed ID: 33133822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration].
    Riedel AM; Lackerbauer C; Lohmann CP; Ulbig M
    Ophthalmologe; 2022 Jan; 119(1):75-78. PubMed ID: 33575902
    [No Abstract]   [Full Text] [Related]  

  • 20. Brolucizumab-foreseeable workflow in the current scenario.
    Sharma A; Kumar N; Parachuri N; Kuppermann BD; Bandello F; Regillo CD; Boyer D; Nguyen QD
    Eye (Lond); 2021 Jun; 35(6):1548-1550. PubMed ID: 33531697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.